Technical Scrutiny: Vivus Inc., Sanofi, DENTSPLY Intl., and Acura Pharma Editor Note: For more information about this release, please scroll to bottom. PR Newswire LONDON, August 9, 2013 LONDON, August 9, 2013 /PRNewswire/ -- On Thursday August 8, 2013, shares in healthcare companies ended on a higher note, tracking gains in the broader market. The major movers in the healthcare sector on Thursday included Vivus Inc. (NASDAQ: VVUS), Sanofi (NYSE: SNY), DENTSPLY International Inc. (NASDAQ: XRAY), and Acura Pharmaceuticals Inc. (NASDAQ: ACUR). AAAResearchReports.com tracked VVUS, SNY, XRAY, and ACUR. These reports can be seen for free at: http://www.aaaresearchreports.com/register/ Vivus Inc.'s shares moved higher on Thursday, reversing some of their recent losses. The company's shares ended the day at an intraday high of $14.16, up 0.78% from the previous closing price. A total of 2.16 million shares were traded, which is below the daily average volume of 2.57 million. The stock is up 12.92% in the last one month, outperforming the S&P 500 which has gained 3.48% during the same period. Further, the stock is currently trading above its 50-day and 200-day moving averages. Download free research on VVUS by signing up now at: http://www.AAAResearchReports.com/VVUS080913.pdf Shares in Sanofi gained 0.98% on Thursday, extending their gains from previous trading sessions. The company's shares fluctuated between $52.41 and $52.99, before finishing the day at $52.79. A total of 2.29 million shares were traded, which is above the daily average volume of 1.21 million. Sanofi's shares have gained 3.47% in the last three trading sessions, outperforming the S&P 500 which has declined 0.57% during the same period. Register for today's free analysis on SNY at: http://www.AAAResearchReports.com/SNY080913.pdf Shares in DENTSPLY International Inc. closed the day 0.85% higher at $42.76 after oscillating between $42.37 and $42.79. A total of 0.56 million shares were traded, which is below the daily average volume of 0.85 million. The company's shares have gained 0.14% in the last three trading sessions and 2.30% in the last one month. A free report on XRAY can be accessed by registering at: http://www.AAAResearchReports.com/XRAY080913.pdf Shares in Acura Pharmaceuticals Inc. moved higher on Thursday, tracking gains in the broader market. The company's shares closed the day up 0.56%, at $1.78, after oscillating between $1.77 and $1.81. A total of 0.18 million shares were traded, which is below the daily average volume of 0.48 million. In the last three months, the stock has lost 17.59%, underperforming the S&P 500 which has gained 3.97% in the same period. Further, the stock is trading below its 50-day and 200-day moving averages. Register with AAA Research Reports and download research on ACUR for free at: http://www.AAAResearchReports.com/ACUR080913.pdf EDITOR NOTES: 1.This is not company news. We are an independent source and our views do not reflect the companies mentioned. 2.Information in this release is fact checked and produced on a best efforts basis and reviewed by a CFA ® charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below. 3.This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public. 4.If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com. 5.For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com. 6.Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration. COMPLIANCE PROCEDURE Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider has, through Chartered Financial Analysts, only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be. NOT FINANCIAL ADVICE Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein. AAAresearchreports.com SOURCE AAA Research Reports Contact: Phone #: + 1-(646)-396-9126
Technical Scrutiny: Vivus Inc., Sanofi, DENTSPLY Intl., and Acura Pharma
Press spacebar to pause and continue. Press esc to stop.